FACTORES DE RIESGO CARDIOVASCULARES NO VALORADOS EN LA MUJER

11_maria_paniagua
By: María Paniagua MD FACC FESC
Vice Presidente
Sociedad Interamericana de Cardiología

More articles by this author

Recambio valvular aórtico tradicional: PARTNER 5 anos

By: Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil

Estenosis aórtica severa con bajo flujo, bajo gradiente y disfunción sistólica

By: Rubén G. Servián C. MD Departamento de Imágenes – Hospital Central Instituto de Previsión Social (I.P.S.)

Angioplastía en Tronco coronario izquierdo y Enfermedad de Múltiples Vasos. Nuevas evidencias 2015.

By: Dr. Marcelo Halac Hospital Italiano - Buenos Aires

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Dynamic Coronary Roadmap: does it really help reduce contrast use?

Contrast-induced nephropathy remains a relevant complication of percutaneous coronary interventions (PCI), particularly in patients with multiple comorbidities and complex coronary anatomies. Dynamic Coronary Roadmap...

Endoleaks after endovascular repair of complex aortic aneurysms: always reintervene or monitor with CTA?

Endovascular repair of thoracoabdominal aneurysms requiring sealing above the renal arteries, with preservation of visceral vessels using fenestrated and/or branched devices (F/B-EVAR), has become...

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...